Abano Healthcare Group Limited reported unaudited consolidated earnings results for the six months ended November 30, 2011. For the period, the company reported revenues of NZD 101,998,000 compared to NZD 86,680,000 a year ago. Operating profit was NZD 7,736,000 and NZD 7,250,000 a year ago. Profit before income tax was NZD 3,520,000 and NZD 5,145,000 a year ago. Profit attributable to equity holders of the company share of profit was NZD 573,000 or 3.62 cents per basic and diluted share compared to NZD 2,197,000 or 10.51 cents per basic and diluted share a year ago. Net cash generated from operating activities was NZD 8,541,000 compared to NZD 9,581,000 a year ago. Purchase of intangible assets and property, plant and equipment was NZD 3,479,000 compared to NZD 3,183,000 a year ago. EBITDA was NZD 11.7 million compared to NZD 10.3 million a year ago. Underlying EBITDA was NZD 12.5 million compared to NZD 10.8 million a year ago. Underlying NPAT was NZD 1.3 million or 8.29 cents per basic and diluted share compared to NZD 2.8 million or 13.51 cents per basic and diluted share a year ago. The company expects to see good growth continue at revenue and EBITDA for the full year ended May 31, 2012, there will be as light decrease in the bottom line performance at NPAT after expensing investment costs as required by IFRS. Due to increased acquisition rate, the company expects these one off acquisition costs to be higher than the previous financial year.